Analyst Ratings for Aurinia Pharmaceuticals (AUPH)
AUPH Rating Summary
AUPH Price Target Summary
- Highest: $21.00 (Jefferies)
- Lowest: $15.00 (RBC Capital)
- Average: $17.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$17.25 (+8.1%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$17.25 (+8.1%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/3/2025 | Leerink | Joseph Schwartz | Downgrade | Market Perform (Outperform) |
16.00 (N/A) |
15.91 (15.96) |
0.31% | Details |
| 11/7/2025 | Jefferies | Maury Raycroft | Upgrade | Buy (Hold) |
21.00 (10.00) |
14.45 (15.96) |
10.45% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
